Statistics for Ventyx Biosciences, (id:7571 VTYX)

Valuation metrics

Market cap

132.23M

Enterprise value

-131,560,056.00

Trailing P/E (ttm)

-0.56

Forward P/E

-0.87

PEG ratio

-0.87

Price/Sales (ttm)

Price/Book (mrq)

0.47

Enterprise Value/Revenue

Enterprise Value/EBITDA

0.79

Overview

Shares outstanding

70.71M

Float

49.72M

Shares short

8.14M

% Held by insiders

0.03%

% Held by institutions

0.85%

Average volume (10 days)

987.10K

Average volume (90 days)

Price summary

52-Week low

1.67

52-Week high

11.48

52-Week change

-27.57%

Beta

0.37

50-Day moving average

2.23

200-Day moving average

3.57

Dividends and splits

Forward annual dividend rate

Forward annual dividend yield

Trailing annual dividend rate

0.00%

Trailing annual dividend yield

0.00

5-Year annual dividend yield

Payout ratio

0.00

Dividend date

Ex-dividend date

Last split factor

2:1

Last split date

Financials

Fiscal year

Fiscal year ends

December 31th, 2023

Most recent quarter (mrq)

September 30th, 2024

Profitability

Profit margin

0.00%

Operating margin

0.00%

Operational effectiveness

Return on assets

-33.39%

Return on equity

-54.24%

Income statement

Revenue (ttm)

0.00

Revenue per share (ttm)

0.00

Quarterly revenue growth (yoy)

Gross profit (ttm)

0.00

EBITDA

-166,116,992.00

Net income to common (ttm)

-152,524,000.00

Diluted EPS (ttm)

-2.35

Quarterly earnings growth (yoy)

Balance sheet

Total cash (mrq)

274.82M

Total cash per share (mrq)

3.89

Total debt (mrq)

11.04M

Total Debt/Equity (mrq)

3.96

Current ratio (mrq)

2.35K%

Book value per share (mrq)

3.94

Cash flow

Cash flow statement

-159,279,008.00

Levered free cash flow (LFCF)

-100,833,248.00